The silent signal: What swollen legs can reveal about pancreatic cancer
It is not uncommon for the human body to show internal stress through symptoms that at first seem to have nothing to do with the actual source of the illness.
Many serious diseases, including cancer, often begin silently and initially cause only mild signs before more noticeable symptoms appear.
The pancreas, which is located in the abdominal cavity behind the stomach, plays a crucial role in digestion and in regulating blood sugar levels.
Because of its deep position in the body, diseases of the pancreas often progress without causing clear symptoms in the early stages. For this reason, pancreatic cancer in particular is often only detected when it is already advanced.
Recent scientific studies suggest that the body can sometimes show early warning signs of a disease in unexpected ways. One possible sign is swelling of the lower limbs.
Swollen legs, also known as edema, are commonly associated with kidney disease, heart problems, or poor circulation.
However, more recent clinical studies show that leg swelling can also indicate more serious health issues, including pancreatic cancer, according to research from the National Library of Medicine.
Although edema itself is relatively common, the circumstances of its occurrence can provide important clues about the underlying cause.
Sudden swelling, swelling that is more pronounced in one leg than the other, or persistent swelling without an obvious cause may indicate deeper systemic changes in the body.
Today, researchers know that pancreatic cancer can alter blood composition, circulation patterns, and protein levels in the blood—changes that can sometimes become noticeable through symptoms in the legs.
Recognizing such warning signs can contribute to earlier detection of the disease.
The main cause: Deep vein thrombosis (DVT)
The strongest and most concerning link between swollen legs and pancreatic cancer is the formation of blood clots, particularly a condition known as deep vein thrombosis (DVT).
In this condition, a clot forms deep in a vein—usually in the leg—and blocks normal blood flow. According to the Mayo Clinic, symptoms can include swelling, warmth, pain, and sometimes a change in skin color in the affected area.
Among the various types of cancer, one stands out in particular due to its strong association with such blood clots: pancreatic ductal adenocarcinoma (PDAC).
This type of cancer has such a strong connection to clot formation that doctors often describe it as “procoagulant,” meaning it significantly promotes blood thickening and clotting more than normal.
This effect is not merely a side effect of the disease, but a direct biological result of the cancer’s interaction with the body’s systems.
The biochemistry of Trousseau’s sign
For many years, doctors have known that unexplained blood clots can sometimes indicate hidden cancers. In the 19th century, French physician Armand Trousseau observed that several of his patients developed recrrent clots long before their underlying cancers were diagnosed. This medical phenomenon later became known as Trousseau syndrome.
Modern research has since explained the mechanisms behind this relationship in greater detail. Advances in molecular biology have identified several biological “triggers” used by pancreatic tumors that influence the body’s clotting system.
Overexpression of tissue factor (TF)
Pancreatic tumor cells release large amounts of a protein called tissue factor into the bloodstream.
This protein acts as the body’s primary “emergency trigger” for blood clotting, initiating the coagulation cascade—a complex sequence of reactions that ultimately leads to the formation of a blood clot.
In addition, cancer cells release microscopic particles into the bloodstream that contain tissue factor. These particles circulate throughout the body and spread clot-promoting signals to distant areas. They often settle in the legs, where blood clots can then form.
Adenocarcinoma mucins
Another important factor is mucins—large, sugar-coated proteins produced by many pancreatic tumors. When these mucins enter the bloodstream, they act like sticky bridges that attach to platelets and white blood cells.
This interaction activates the cells in a way that strongly promotes blood clot formation, as described in studies in the Journal of Mind and Medical Science.
Together, these mechanisms create a condition that doctors sometimes refer to as “sticky blood”—a situation in which the body’s natural clotting system remains continuously activated, significantly increasing the risk of dangerous vascular blockages.
Why the legs are affected
According to a study published in the National Library of Medicine, blood in the deep veins of the legs naturally moves more slowly than in many other parts of the body.
This happens because gravity opposes the upward flow of blood and because the legs are located far from the heart. As a result, this area is particularly prone to the formation of blood clots.
When abnormal clotting signals spread throughout the body, the legs are among the most common places where a blockage can develop.
Once a clot begins to form, it disrupts normal blood flow and quickly leads to swelling and inflammation in the affected area. Some people also notice pain, warmth, or redness, but in many patients the only visible warning sign is swelling in the leg.
Statistical risks: the Khorana Score
Clinical evidence consistently confirms a strong link between pancreatic cancer and conditions associated with blood clots.
Among all types of cancer, pancreatic cancer ranks second in terms of the risk of developing venous thromboembolism (VTE), a condition that includes both deep vein thrombosis (DVT) and pulmonary embolism.
More recent estimates from 2024 and 2025 suggest that approximately 20% to 40% of people with advanced pancreatic cancer will experience a clotting event at some point during the course of their illness. As a result, clotting disorders are among the most common complications of this disease.
The Khorana Risk Score
To determine which cancer patients are at the highest risk of developing blood clots, physicians often use a predictive model known as the Khorana Risk Score.
This model evaluates several factors, including the type of cancer, platelet count, hemoglobin concentration, and body mass index.
Each type of cancer is assigned a baseline score based on its known risk for clotting complications. Pancreatic cancer automatically receives two points, which places patients directly into the high-risk category even before other risk factors are considered.
Prognostic significance
In people with pancreatic cancer, blood clots are not only a complication of the disease—they can also provide clues about how severe the illness is.
Research associated with the COMPASS study in 2025 suggests that the early occurrence of blood clots may be linked to particularly aggressive tumor subtypes.
If a venous thromboembolism occurs within the first three months after diagnosis, it is often associated with tumors that have biological characteristics promoting faster growth and poorer survival outcomes.
Because of this association, doctors consider sudden or unexplained leg swelling as a possible warning sign that the disease may be progressing more aggressively.
Protein deficiency and systemic edema
Not all swelling related to pancreatic disease is caused by blood clots. In some cases, swelling in both legs can occur due to a condition known as systemic edema.
This develops when the body’s fluid balance is disrupted, as explained by the Mayo Clinic.
Albumin, a protein produced by the liver, plays an important role in keeping fluid within blood vessels. If albumin levels drop too low, fluid begins to leak from the vessels into surrounding tissues, causing swelling.
Pancreatic tumors can disrupt this process because they may block the release of important digestive enzymes. Without these enzymes, the body cannot properly absorb proteins from food.
Over time, this can lead to a condition known as hypoalbuminemia, especially in advanced stages of the disease. In some cases, the tumor may also impair liver function or trigger widespread inflammation in the body, further lowering albumin levels.
This type of swelling often appears as pitting edema and is usually most noticeable in the ankles and feet.
A simple way to check for this type of edema is to gently press a finger on the swollen area—if a temporary indentation remains, it may indicate this condition.
Unlike swelling caused by deep vein thrombosis, which typically affects only one leg, systemic edema usually develops gradually and affects both legs.
Diagnostic pathways: when swelling leads to discovery
In some cases, leg swelling can be the earliest sign that ultimately leads to the discovery of pancreatic cancer.
Because of this possibility, medical guidelines—such as the ESMO recommendations published in 2025—advise careful medical evaluation when leg swelling occurs without an obvious cause.
This recommendation is particularly important for people over 50 or for those with additional risk factors, including a history of smoking or unexplained weight loss.
The diagnostic process when pancreatic disease is suspected usually begins with initial tests. Physicians often start with a blood test measuring D-dimer levels—proteins that appear when the body breaks down a blood clot.
Research by Seitz and colleagues in 2024 showed that elevated D-dimer levels may indicate the presence of a clot, although the test alone cannot confirm a definitive diagnosis.
If deep vein thrombosis (DVT) is suspected, imaging studies typically follow. According to the Mayo Clinic, duplex ultrasound is among the first methods used. This examination allows doctors to observe blood flow in the veins and determine whether it is slowed or blocked.
Another important step is identifying possible underlying cancers. If a DVT occurs without an obvious trigger—such as recent surgery or a long journey—it is referred to as unprovoked. In such cases, the National Cancer Institute stated in 2025 that physicians may order CT or MRI scans of the abdomen to look for hidden cancers, including pancreatic cancer. Investigating unexplained clotting events can sometimes lead to the discovery of cancer at an earlier stage than would otherwise be the case.
Treatment and new therapeutic strategies (2025–2026)
When leg swelling is associated with pancreatic cancer, treatment focuses both on relieving the swelling and addressing the underlying cause.
Anticoagulation therapy
Once a blood clot is detected, doctors often prescribe anticoagulant medications, such as direct oral anticoagulants (DOACs) or low–molecular-weight heparins (LMWH). These medications help prevent the clot from growing and reduce the risk of new clots forming. They also significantly lower the likelihood of serious complications, including pulmonary embolism.
Preventive strategies
More recent findings reported in ASCO Post suggest that high-risk patients may benefit from preventive treatment with blood-thinning medications already at the time of cancer diagnosis, in order to reduce the likelihood of blood clot formation.
In addition to medical treatment, some practical measures can also help relieve symptoms and reduce fluid retention. According to the Mayo Clinic, these include:
Wearing compression stockings to improve circulation
Elevating the legs while resting
Staying physically active, for example through light exercise such as walking